Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Additionally, tirzepatide, a dual glucose-dependent insulinotropic polypeptide and GLP-1 receptor agonist, was approved in May 2022 for adults with T2DM (Mounjaro , Eli Lilly and Company) and in November 2023 for chronic weight management (Zepbound , Eli Lilly and Company) [11, 12]
Cost per pound lost This is the metric that matters most for value-conscious patients
Looking for an Injection to Lose Weight
How Retatrutide Works Retatrutide is a next-generation medication that activates GLP-1, GIP, and glucagon receptors , meaning it works on three metabolic pathways instead of one
Contrave is a combination medication containing naltrexone hydrochloride and bupropion hydrochloride in an extended-release tablet
We help you better understand healthy eating, exercise and other habits that can help you lose weight and keep it off for good
US$ 21.70
US$ 28.33
US$ 23.35
US$ 28.97
